10-K Filing

CVS HEALTH CORP CIK: 64803 FY 2023

Filing Information

Form Type	10-K
Accession Number	`0000064803-24-000007`
Period End Date	20231231
Filing Date	20240207
Fiscal Year	2023
Fiscal Period	FY
XBRL Instance	cvs-20231231_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 109 Income Statement 80 Cash Flow Statement 143 Stockholders Equity 40 Comprehensive Income 30

Balance Sheet 109 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$9.41B	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$8.20B	USD	Point-in-time
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	100,000.00	shares	Point-in-time
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	100,000.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$12.95B	USD	Point-in-time
Preferred stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Investments	`ShortTermInvestments`	$3.26B	USD	Point-in-time
Investments	`ShortTermInvestments`	$2.78B	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$35.23B	USD	Point-in-time
Preferred stock, shares outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$27.28B	USD	Point-in-time
Preferred stock, shares outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Inventories	`InventoryNet`	$18.02B	USD	Point-in-time
Inventories	`InventoryNet`	$19.09B	USD	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	3.20B	shares	Point-in-time
Assets held for sale	`AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent`	-	USD	Point-in-time
Assets held for sale	`AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent`	$908.00M	USD	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	3.20B	shares	Point-in-time
Other current assets	`OtherAssetsCurrent`	$3.15B	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$2.64B	USD	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	1.76B	shares	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	1.77B	shares	Point-in-time
Total current assets	`AssetsCurrent`	$65.63B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$67.86B	USD	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	1.30B	shares	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	1.29B	shares	Point-in-time
Long-term investments	`LongTermInvestments`	$21.10B	USD	Point-in-time
Treasury stock (in shares)	`TreasuryStockCommonShares`	458.00M	shares	Point-in-time
Treasury stock (in shares)	`TreasuryStockCommonShares`	480.00M	shares	Point-in-time
Long-term investments	`LongTermInvestments`	$23.02B	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization`	$12.87B	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization`	$13.18B	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$17.87B	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$17.25B	USD	Point-in-time
Goodwill	`Goodwill`	$79.12B	USD	Point-in-time
Goodwill	`Goodwill`	$91.27B	USD	Point-in-time
Goodwill	`Goodwill`	$78.15B	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$29.23B	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$24.80B	USD	Point-in-time
Separate accounts assets	`SeparateAccountAssets`	$3.25B	USD	Point-in-time
Separate accounts assets	`SeparateAccountAssets`	$3.23B	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$4.66B	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$4.62B	USD	Point-in-time
Total assets	`Assets`	$228.28B	USD	Point-in-time
Total assets	`Assets`	$249.73B	USD	Point-in-time
Accounts payable	`AccountsPayableTradeCurrent`	$14.84B	USD	Point-in-time
Accounts payable	`AccountsPayableTradeCurrent`	$14.90B	USD	Point-in-time
Pharmacy claims and discounts payable	`PharmacyClaimsAndDiscountsPayableCurrent`	$19.42B	USD	Point-in-time
Pharmacy claims and discounts payable	`PharmacyClaimsAndDiscountsPayableCurrent`	$22.87B	USD	Point-in-time
Health care costs payable	`LiabilityForClaimsAndClaimsAdjustmentExpenseAndHealthCareOrganizationAccountsPayableToThirdPartyPayor`	$12.05B	USD	Point-in-time
Health care costs payable	`LiabilityForClaimsAndClaimsAdjustmentExpense`	$10.14B	USD	Point-in-time
Policyholders funds	`OtherPolicyholderFunds`	$1.33B	USD	Point-in-time
Policyholders funds	`OtherPolicyholderFunds`	$1.50B	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$18.75B	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$22.19B	USD	Point-in-time
Other insurance liabilities	`OtherInsuranceLiabilitiesCurrent`	$1.09B	USD	Point-in-time
Other insurance liabilities	`OtherInsuranceLiabilitiesCurrent`	$1.14B	USD	Point-in-time
Current portion of operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$1.74B	USD	Point-in-time
Current portion of operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$1.68B	USD	Point-in-time
Short-term debt	`ShortTermBorrowings`	$200.00M	USD	Point-in-time
Short-term debt	`ShortTermBorrowings`	-	USD	Point-in-time
Current portion of long-term debt	`LongTermDebtAndCapitalLeaseObligationsCurrent`	$2.77B	USD	Point-in-time
Current portion of long-term debt	`LongTermDebtAndCapitalLeaseObligationsCurrent`	$1.78B	USD	Point-in-time
Liabilities held for sale	`LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent`	-	USD	Point-in-time
Liabilities held for sale	`LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent`	$228.00M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$69.42B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$79.19B	USD	Point-in-time
Long-term operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$16.03B	USD	Point-in-time
Long-term operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$16.80B	USD	Point-in-time
Long-term debt	`LongTermDebtAndCapitalLeaseObligations`	$58.64B	USD	Point-in-time
Long-term debt	`LongTermDebtAndCapitalLeaseObligations`	$50.48B	USD	Point-in-time
Deferred income taxes	`DeferredIncomeTaxLiabilitiesNet`	$4.31B	USD	Point-in-time
Deferred income taxes	`DeferredIncomeTaxLiabilitiesNet`	$4.02B	USD	Point-in-time
Separate accounts liabilities	`SeparateAccountsLiability`	$5.09B	USD	Point-in-time
Separate accounts liabilities	`SeparateAccountsLiability`	$3.23B	USD	Point-in-time
Separate accounts liabilities	`SeparateAccountsLiability`	$3.25B	USD	Point-in-time
Other long-term insurance liabilities	`OtherInsuranceLiabilitiesNoncurrent`	$5.46B	USD	Point-in-time
Other long-term insurance liabilities	`OtherInsuranceLiabilitiesNoncurrent`	$5.83B	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$6.21B	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$6.73B	USD	Point-in-time
Total liabilities	`Liabilities`	$173.09B	USD	Point-in-time
Total liabilities	`Liabilities`	$156.51B	USD	Point-in-time
Commitments and contingencies (Note 18)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 18)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, par value $0.01: 0.1 shares authorized; none issued or outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, par value $0.01: 0.1 shares authorized; none issued or outstanding	`PreferredStockValue`	-	USD	Point-in-time
Common stock, par value $0.01: 3,200 shares authorized; 1,768 shares issued and 1,288 shares outstanding at December 31, 2023 and 1,758 shares issued and 1,300 shares outstanding at December 31, 2022 and capital surplus	`CommonStocksIncludingAdditionalPaidInCapital`	$48.19B	USD	Point-in-time
Common stock, par value $0.01: 3,200 shares authorized; 1,768 shares issued and 1,288 shares outstanding at December 31, 2023 and 1,758 shares issued and 1,300 shares outstanding at December 31, 2022 and capital surplus	`CommonStocksIncludingAdditionalPaidInCapital`	$48.99B	USD	Point-in-time
Treasury stock, at cost: 480 and 458 shares at December 31, 2023 and 2022	`TreasuryStockCommonValue`	$33.84B	USD	Point-in-time
Treasury stock, at cost: 480 and 458 shares at December 31, 2023 and 2022	`TreasuryStockCommonValue`	$31.86B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$56.40B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$61.60B	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-1.26B	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-297.00M	USD	Point-in-time
Total CVS Health shareholders equity	`StockholdersEquity`	$71.47B	USD	Point-in-time
Total CVS Health shareholders equity	`StockholdersEquity`	$76.46B	USD	Point-in-time
Noncontrolling interests	`MinorityInterest`	$175.00M	USD	Point-in-time
Noncontrolling interests	`MinorityInterest`	$300.00M	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$69.70B	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$71.77B	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$76.64B	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$74.84B	USD	Point-in-time
Total liabilities and shareholders equity	`LiabilitiesAndStockholdersEquity`	$249.73B	USD	Point-in-time
Total liabilities and shareholders equity	`LiabilitiesAndStockholdersEquity`	$228.28B	USD	Point-in-time

Income Statement 80 line items

Line Item	Tag	Value	Unit	Period
Premiums	`PremiumsEarnedNet`	$76.13B	USD	Annual
Premiums	`PremiumsEarnedNet`	$85.33B	USD	Annual
Premiums	`PremiumsEarnedNet`	$99.19B	USD	Annual
Net investment income	`NetInvestmentIncome`	$1.20B	USD	Annual
Net investment income	`NetInvestmentIncome`	$838.00M	USD	Annual
Net investment income	`NetInvestmentIncome`	$1.15B	USD	Annual
Total revenues	`Revenues`	$292.11B	USD	Annual
Total revenues	`Revenues`	$357.78B	USD	Annual
Total revenues	`Revenues`	$322.47B	USD	Annual
Cost of products sold	`CostOfGoodsAndServicesSold`	$196.89B	USD	Annual
Cost of products sold	`CostOfGoodsAndServicesSold`	$175.80B	USD	Annual
Cost of products sold	`CostOfGoodsAndServicesSold`	$217.10B	USD	Annual
Health care costs	`PolicyholderBenefitsAndClaimsIncurredHealthCare`	$86.25B	USD	Annual
Health care costs	`PolicyholderBenefitsAndClaimsIncurredHealthCare`	$71.07B	USD	Annual
Health care costs	`PolicyholderBenefitsAndClaimsIncurredHealthCare`	$64.19B	USD	Annual
Restructuring charges	`RestructuringCostsAndAssetImpairmentCharges`	-	USD	Annual
Restructuring charges	`RestructuringCostsAndAssetImpairmentCharges`	$507.00M	USD	Annual
Restructuring charges	`RestructuringCostsAndAssetImpairmentCharges`	-	USD	Annual
Opioid litigation charges	`GainLossRelatedToLitigationSettlement`	$-5.80B	USD	Annual
Opioid litigation charges	`GainLossRelatedToLitigationSettlement`	-	USD	Annual
Opioid litigation charges	`GainLossRelatedToLitigationSettlement`	-	USD	Annual
Loss on assets held for sale	`ImpairmentOfLongLivedAssetsToBeDisposedOf`	$2.53B	USD	Annual
Loss on assets held for sale	`ImpairmentOfLongLivedAssetsToBeDisposedOf`	$349.00M	USD	Annual
Loss on assets held for sale	`ImpairmentOfLongLivedAssetsToBeDisposedOf`	-	USD	Annual
Store impairments	`StoreImpairmentCharges`	-	USD	Annual
Store impairments	`StoreImpairmentCharges`	-	USD	Annual
Store impairments	`StoreImpairmentCharges`	$1.36B	USD	Annual
Goodwill impairment	`GoodwillImpairmentLoss`	-	USD	Annual
Goodwill impairment	`GoodwillImpairmentLoss`	$431.00M	USD	Annual
Goodwill impairment	`GoodwillImpairmentLoss`	-	USD	Annual
Operating expenses	`OtherCostAndExpenseOperating`	$39.83B	USD	Annual
Operating expenses	`OtherCostAndExpenseOperating`	$37.02B	USD	Annual
Operating expenses	`OtherCostAndExpenseOperating`	$38.21B	USD	Annual
Total operating costs	`CostsAndExpenses`	$278.80B	USD	Annual
Total operating costs	`CostsAndExpenses`	$314.51B	USD	Annual
Total operating costs	`CostsAndExpenses`	$344.03B	USD	Annual
Operating income	`OperatingIncomeLoss`	$13.74B	USD	Annual
Operating income	`OperatingIncomeLoss`	$7.95B	USD	Annual
Operating income	`OperatingIncomeLoss`	$13.31B	USD	Annual
Interest expense	`InterestExpense`	$2.66B	USD	Annual
Interest expense	`InterestExpense`	$2.29B	USD	Annual
Interest expense	`InterestExpense`	$2.50B	USD	Annual
Loss on early extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-363.00M	USD	Point-in-time
Loss on early extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-452.00M	USD	Annual
Loss on early extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-89.00M	USD	Point-in-time
Loss on early extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	-	USD	Annual
Loss on early extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	-	USD	Annual
Other income	`OtherNonoperatingIncomeExpense`	$169.00M	USD	Annual
Other income	`OtherNonoperatingIncomeExpense`	$182.00M	USD	Annual
Other income	`OtherNonoperatingIncomeExpense`	$88.00M	USD	Annual
Income before income tax provision	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$10.54B	USD	Annual
Income before income tax provision	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$5.84B	USD	Annual
Income before income tax provision	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$11.17B	USD	Annual
Income tax provision	`IncomeTaxExpenseBenefit`	$2.81B	USD	Annual
Income tax provision	`IncomeTaxExpenseBenefit`	$2.55B	USD	Annual
Income tax provision	`IncomeTaxExpenseBenefit`	$1.51B	USD	Annual
Net income	`ProfitLoss`	$8.37B	USD	Annual
Net income	`ProfitLoss`	$4.33B	USD	Annual
Net income	`ProfitLoss`	$7.99B	USD	Annual
Net (income) loss attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$16.00M	USD	Annual
Net (income) loss attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$24.00M	USD	Annual
Net (income) loss attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-12.00M	USD	Annual
Net income attributable to CVS Health	`NetIncomeLoss`	$4.31B	USD	Annual
Net income attributable to CVS Health	`NetIncomeLoss`	$8.34B	USD	Annual
Net income attributable to CVS Health	`NetIncomeLoss`	$8.00B	USD	Annual
Basic (in dollars per share)	`EarningsPerShareBasic`	$6.07	USD	Annual
Basic (in dollars per share)	`EarningsPerShareBasic`	$3.29	USD	Annual
Basic (in dollars per share)	`EarningsPerShareBasic`	$6.49	USD	Annual
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$6.02	USD	Annual
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$6.47	USD	Annual
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$3.26	USD	Annual
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	1.32B	shares	Annual
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	1.31B	shares	Annual
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	1.28B	shares	Annual
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	1.33B	shares	Annual
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	1.32B	shares	Annual
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	1.29B	shares	Annual
Dividends declared per share (in dollars per share)	`CommonStockDividendsPerShareDeclared`	$2.00	USD	Annual
Dividends declared per share (in dollars per share)	`CommonStockDividendsPerShareDeclared`	$2.20	USD	Annual
Dividends declared per share (in dollars per share)	`CommonStockDividendsPerShareDeclared`	$2.42	USD	Annual

Cash Flow Statement 143 line items

Line Item	Tag	Value	Unit	Period
Cash and restricted cash sold	`CashDivestedFromDeconsolidation`	$2.85B	USD	Annual
Cash receipts from customers	`ProceedsFromCustomers`	$284.22B	USD	Annual
Cash receipts from customers	`ProceedsFromCustomers`	$313.66B	USD	Annual
Cash receipts from customers	`ProceedsFromCustomers`	$345.46B	USD	Annual
Cash paid for inventory, prescriptions dispensed and health services rendered	`PaymentsForInventoryAndPrescriptionsDispensedByRetailNetworkPharmacies`	$189.77B	USD	Annual
Cash paid for inventory, prescriptions dispensed and health services rendered	`PaymentsForInventoryAndPrescriptionsDispensedByRetailNetworkPharmacies`	$165.78B	USD	Annual
Cash paid for inventory, prescriptions dispensed and health services rendered	`PaymentsForInventoryAndPrescriptionsDispensedByRetailNetworkPharmacies`	$208.85B	USD	Annual
Insurance benefits paid	`PaymentsForInsuranceBenefits`	$63.60B	USD	Annual
Insurance benefits paid	`PaymentsForInsuranceBenefits`	$69.73B	USD	Annual
Insurance benefits paid	`PaymentsForInsuranceBenefits`	$84.10B	USD	Annual
Cash paid to other suppliers and employees	`PaymentsToSuppliersAndEmployees`	$31.65B	USD	Annual
Cash paid to other suppliers and employees	`PaymentsToSuppliersAndEmployees`	$32.66B	USD	Annual
Cash paid to other suppliers and employees	`PaymentsToSuppliersAndEmployees`	$34.73B	USD	Annual
Interest and investment income received	`ProceedsFromInterestAndDividendsReceived`	$743.00M	USD	Annual
Interest and investment income received	`ProceedsFromInterestAndDividendsReceived`	$1.03B	USD	Annual
Interest and investment income received	`ProceedsFromInterestAndDividendsReceived`	$1.58B	USD	Annual
Interest paid	`InterestPaidNet`	$2.47B	USD	Annual
Interest paid	`InterestPaidNet`	$2.24B	USD	Annual
Interest paid	`InterestPaidNet`	$2.42B	USD	Annual
Income taxes paid	`IncomeTaxesPaidNet`	$3.52B	USD	Annual
Income taxes paid	`IncomeTaxesPaidNet`	$4.12B	USD	Annual
Income taxes paid	`IncomeTaxesPaidNet`	$3.19B	USD	Annual
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$16.18B	USD	Annual
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$13.43B	USD	Annual
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$18.27B	USD	Annual
Proceeds from sales and maturities of investments	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$7.25B	USD	Annual
Proceeds from sales and maturities of investments	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$7.73B	USD	Annual
Proceeds from sales and maturities of investments	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$6.73B	USD	Annual
Purchases of investments	`PaymentsToAcquireInvestments`	$9.96B	USD	Annual
Purchases of investments	`PaymentsToAcquireInvestments`	$7.75B	USD	Annual
Purchases of investments	`PaymentsToAcquireInvestments`	$9.04B	USD	Annual
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$2.73B	USD	Annual
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$2.52B	USD	Annual
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$3.03B	USD	Annual
Acquisitions (net of cash and restricted cash acquired)	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$139.00M	USD	Annual
Acquisitions (net of cash and restricted cash acquired)	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$146.00M	USD	Annual
Acquisitions (net of cash and restricted cash acquired)	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$16.61B	USD	Annual
Proceeds from sale of subsidiaries (net of cash and restricted cash sold of $2,854 in 2022)	`ProceedsFromDivestitureOfBusinessesNetOfCashDivested`	-	USD	Annual
Proceeds from sale of subsidiaries (net of cash and restricted cash sold of $2,854 in 2022)	`ProceedsFromDivestitureOfBusinessesNetOfCashDivested`	-	USD	Annual
Proceeds from sale of subsidiaries (net of cash and restricted cash sold of $2,854 in 2022)	`ProceedsFromDivestitureOfBusinessesNetOfCashDivested`	$-1.25B	USD	Annual
Other	`PaymentsForProceedsFromOtherInvestingActivities`	$-85.00M	USD	Annual
Other	`PaymentsForProceedsFromOtherInvestingActivities`	$-68.00M	USD	Annual
Other	`PaymentsForProceedsFromOtherInvestingActivities`	$-122.00M	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-5.05B	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-5.26B	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-20.89B	USD	Annual
Commercial paper borrowings (repayments), net	`ProceedsFromRepaymentsOfCommercialPaper`	-	USD	Annual
Commercial paper borrowings (repayments), net	`ProceedsFromRepaymentsOfCommercialPaper`	$200.00M	USD	Annual
Commercial paper borrowings (repayments), net	`ProceedsFromRepaymentsOfCommercialPaper`	-	USD	Annual
Proceeds from issuance of short-term loan	`ProceedsFromOtherShortTermDebt`	-	USD	Annual
Proceeds from issuance of short-term loan	`ProceedsFromOtherShortTermDebt`	$5.00B	USD	Annual
Proceeds from issuance of short-term loan	`ProceedsFromOtherShortTermDebt`	-	USD	Annual
Repayment of short-term loan	`RepaymentsOfOtherShortTermDebt`	-	USD	Annual
Repayment of short-term loan	`RepaymentsOfOtherShortTermDebt`	$5.00B	USD	Annual
Repayment of short-term loan	`RepaymentsOfOtherShortTermDebt`	-	USD	Annual
Proceeds from issuance of long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	$10.90B	USD	Annual
Proceeds from issuance of long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	-	USD	Annual
Proceeds from issuance of long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	$987.00M	USD	Annual
Repayments of long-term debt	`RepaymentsOfLongTermDebt`	$10.25B	USD	Annual
Repayments of long-term debt	`RepaymentsOfLongTermDebt`	$3.17B	USD	Annual
Repayments of long-term debt	`RepaymentsOfLongTermDebt`	$4.21B	USD	Annual
Repurchase of common stock	`PaymentsForRepurchaseOfCommonStock`	$2.01B	USD	Annual
Repurchase of common stock	`PaymentsForRepurchaseOfCommonStock`	$3.50B	USD	Annual
Repurchase of common stock	`PaymentsForRepurchaseOfCommonStock`	-	USD	Annual
Dividends paid	`PaymentsOfDividends`	$2.91B	USD	Annual
Dividends paid	`PaymentsOfDividends`	$3.13B	USD	Annual
Dividends paid	`PaymentsOfDividends`	$2.62B	USD	Annual
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$277.00M	USD	Annual
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$549.00M	USD	Annual
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$551.00M	USD	Annual
Payments for taxes related to net share settlement of equity awards	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$181.00M	USD	Annual
Payments for taxes related to net share settlement of equity awards	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$370.00M	USD	Annual
Payments for taxes related to net share settlement of equity awards	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$168.00M	USD	Annual
Other	`ProceedsFromPaymentsForOtherFinancingActivities`	$-79.00M	USD	Annual
Other	`ProceedsFromPaymentsForOtherFinancingActivities`	$-201.00M	USD	Annual
Other	`ProceedsFromPaymentsForOtherFinancingActivities`	$155.00M	USD	Annual
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$2.68B	USD	Annual
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-11.36B	USD	Annual
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-10.52B	USD	Annual
Net increase (decrease) in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-4.78B	USD	Annual
Net increase (decrease) in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$1.65B	USD	Annual
Net increase (decrease) in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$614.00M	USD	Annual
Cash, cash equivalents and restricted cash at the beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$12.69B	USD	Point-in-time
Cash, cash equivalents and restricted cash at the beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$11.04B	USD	Point-in-time
Cash, cash equivalents and restricted cash at the beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$8.53B	USD	Point-in-time
Cash, cash equivalents and restricted cash at the beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$13.30B	USD	Point-in-time
Cash, cash equivalents and restricted cash at the end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$12.69B	USD	Point-in-time
Cash, cash equivalents and restricted cash at the end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$11.04B	USD	Point-in-time
Cash, cash equivalents and restricted cash at the end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$8.53B	USD	Point-in-time
Cash, cash equivalents and restricted cash at the end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$13.30B	USD	Point-in-time
Net income	`ProfitLoss`	$8.37B	USD	Annual
Net income	`ProfitLoss`	$4.33B	USD	Annual
Net income	`ProfitLoss`	$7.99B	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$4.22B	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$4.49B	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$4.37B	USD	Annual
Loss on assets held for sale	`ImpairmentOfLongLivedAssetsToBeDisposedOf`	$2.53B	USD	Annual
Loss on assets held for sale	`ImpairmentOfLongLivedAssetsToBeDisposedOf`	$349.00M	USD	Annual
Loss on assets held for sale	`ImpairmentOfLongLivedAssetsToBeDisposedOf`	-	USD	Annual
Store impairments	`StoreImpairmentCharges`	-	USD	Annual
Store impairments	`StoreImpairmentCharges`	-	USD	Annual
Store impairments	`StoreImpairmentCharges`	$1.36B	USD	Annual
Goodwill impairment	`GoodwillImpairmentLoss`	-	USD	Annual
Goodwill impairment	`GoodwillImpairmentLoss`	$431.00M	USD	Annual
Goodwill impairment	`GoodwillImpairmentLoss`	-	USD	Annual
Stock-based compensation	`ShareBasedCompensation`	$588.00M	USD	Annual
Stock-based compensation	`ShareBasedCompensation`	$484.00M	USD	Annual
Stock-based compensation	`ShareBasedCompensation`	$447.00M	USD	Annual
Gain on sale of subsidiaries	`GainLossOnSaleOfBusiness`	$475.00M	USD	Annual
Gain on sale of subsidiaries	`GainLossOnSaleOfBusiness`	-	USD	Annual
Gain on sale of subsidiaries	`GainLossOnSaleOfBusiness`	-	USD	Annual
Loss on early extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-363.00M	USD	Point-in-time
Loss on early extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-452.00M	USD	Annual
Loss on early extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-89.00M	USD	Point-in-time
Loss on early extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	-	USD	Annual
Loss on early extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	-	USD	Annual
Deferred income taxes	`DeferredIncomeTaxesAndTaxCredits`	$-676.00M	USD	Annual
Deferred income taxes	`DeferredIncomeTaxesAndTaxCredits`	$-2.03B	USD	Annual
Deferred income taxes	`DeferredIncomeTaxesAndTaxCredits`	$-402.00M	USD	Annual
Other noncash items	`OtherNoncashIncomeExpense`	$-416.00M	USD	Annual
Other noncash items	`OtherNoncashIncomeExpense`	$390.00M	USD	Annual
Other noncash items	`OtherNoncashIncomeExpense`	$-332.00M	USD	Annual
Accounts receivable, net	`IncreaseDecreaseInAccountsReceivable`	$2.70B	USD	Annual
Accounts receivable, net	`IncreaseDecreaseInAccountsReceivable`	$6.26B	USD	Annual
Accounts receivable, net	`IncreaseDecreaseInAccountsReceivable`	$2.97B	USD	Annual
Inventories	`IncreaseDecreaseInInventories`	$-735.00M	USD	Annual
Inventories	`IncreaseDecreaseInInventories`	$-1.23B	USD	Annual
Inventories	`IncreaseDecreaseInInventories`	$1.44B	USD	Annual
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$491.00M	USD	Annual
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$510.00M	USD	Annual
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$30.00M	USD	Annual
Accounts payable and pharmacy claims and discounts payable	`IncreaseDecreaseInAccountsPayable`	$4.26B	USD	Annual
Accounts payable and pharmacy claims and discounts payable	`IncreaseDecreaseInAccountsPayable`	$3.62B	USD	Annual
Accounts payable and pharmacy claims and discounts payable	`IncreaseDecreaseInAccountsPayable`	$2.90B	USD	Annual
Health care costs payable and other insurance liabilities	`IncreaseDecreaseInInsuranceLiabilities`	$394.00M	USD	Annual
Health care costs payable and other insurance liabilities	`IncreaseDecreaseInInsuranceLiabilities`	$101.00M	USD	Annual
Health care costs payable and other insurance liabilities	`IncreaseDecreaseInInsuranceLiabilities`	$992.00M	USD	Annual
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$1.54B	USD	Annual
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$6.46B	USD	Annual
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$2.86B	USD	Annual
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$16.18B	USD	Annual
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$13.43B	USD	Annual
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$18.27B	USD	Annual

Stockholders Equity 40 line items

Line Item	Tag	Value	Unit	Period
Treasury shares held in trust (in shares)	`TreasuryStockSharesHeldinTrust`	1.00M	shares	Point-in-time
Treasury shares held in trust (in shares)	`TreasuryStockSharesHeldinTrust`	1.00M	shares	Point-in-time
Treasury shares held in trust (in shares)	`TreasuryStockSharesHeldinTrust`	1.00M	shares	Point-in-time
Treasury shares held in trust	`TreasuryStockValueSharesHeldInTrust`	$29.00M	USD	Point-in-time
Treasury shares held in trust	`TreasuryStockValueSharesHeldInTrust`	$29.00M	USD	Point-in-time
Treasury shares held in trust	`TreasuryStockValueSharesHeldInTrust`	$29.00M	USD	Point-in-time
Common stock	`CommonStockValue`	$18.00M	USD	Point-in-time
Common stock	`CommonStockValue`	$18.00M	USD	Point-in-time
Common stock	`CommonStockValue`	$17.00M	USD	Point-in-time
Treasury shares outstanding, beginning of year balance (in shares)	`TreasuryStockCommonShares`	458.00M	shares	Point-in-time
Treasury shares outstanding, beginning of year balance (in shares)	`TreasuryStockCommonShares`	480.00M	shares	Point-in-time
Beginning of year balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$69.70B	USD	Point-in-time
Beginning of year balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$71.77B	USD	Point-in-time
Beginning of year balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$76.64B	USD	Point-in-time
Beginning of year balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$74.84B	USD	Point-in-time
Net income	`ProfitLoss`	$8.37B	USD	Annual
Net income	`ProfitLoss`	$4.33B	USD	Annual
Net income	`ProfitLoss`	$7.99B	USD	Annual
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-1.60B	USD	Annual
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$967.00M	USD	Annual
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-314.00M	USD	Annual
Stock option activity, stock awards and other	`StockIssuedDuringPeriodValueStockOptionsExercised`	$816.00M	USD	Annual
Stock option activity, stock awards and other	`StockIssuedDuringPeriodValueStockOptionsExercised`	$795.00M	USD	Annual
Stock option activity, stock awards and other	`StockIssuedDuringPeriodValueStockOptionsExercised`	$864.00M	USD	Annual
ESPP issuances, net of purchase of treasury shares	`ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod`	$5.00M	USD	Annual
Purchase of treasury shares, net of ESPP issuances	`TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance`	$1.99B	USD	Annual
Purchase of treasury shares, net of ESPP issuances	`TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance`	$3.69B	USD	Annual
Common stock dividends	`DividendsCommonStock`	$2.91B	USD	Annual
Common stock dividends	`DividendsCommonStock`	$2.64B	USD	Annual
Common stock dividends	`DividendsCommonStock`	$3.14B	USD	Annual
Acquisition of noncontrolling interests	`NoncontrollingInterestIncreaseFromBusinessCombination`	$66.00M	USD	Annual
Other increases (decreases) in noncontrolling interests	`NoncontrollingInterestOtherPeriodIncreaseDecrease`	$-199.00M	USD	Annual
Other increases (decreases) in noncontrolling interests	`NoncontrollingInterestOtherPeriodIncreaseDecrease`	$-22.00M	USD	Annual
Other increases (decreases) in noncontrolling interests	`NoncontrollingInterestOtherPeriodIncreaseDecrease`	$6.00M	USD	Annual
Treasury shares outstanding, end of year balance (in shares)	`TreasuryStockCommonShares`	458.00M	shares	Point-in-time
Treasury shares outstanding, end of year balance (in shares)	`TreasuryStockCommonShares`	480.00M	shares	Point-in-time
End of year balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$69.70B	USD	Point-in-time
End of year balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$71.77B	USD	Point-in-time
End of year balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$76.64B	USD	Point-in-time
End of year balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$74.84B	USD	Point-in-time

Comprehensive Income 30 line items

Line Item	Tag	Value	Unit	Period
Net income	`ProfitLoss`	$8.37B	USD	Annual
Net income	`ProfitLoss`	$4.33B	USD	Annual
Net income	`ProfitLoss`	$7.99B	USD	Annual
Net unrealized investment gains (losses)	`OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent`	$1.09B	USD	Annual
Net unrealized investment gains (losses)	`OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent`	$-2.32B	USD	Annual
Net unrealized investment gains (losses)	`OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent`	$-556.00M	USD	Annual
Change in discount rate on insurance reserves	`OciLiabilityForFuturePolicyBenefitGainLossAfterReclassificationAdjustmentAndTax`	$-67.00M	USD	Annual
Change in discount rate on insurance reserves	`OciLiabilityForFuturePolicyBenefitGainLossAfterReclassificationAdjustmentAndTax`	$255.00M	USD	Annual
Change in discount rate on insurance reserves	`OciLiabilityForFuturePolicyBenefitGainLossAfterReclassificationAdjustmentAndTax`	$870.00M	USD	Annual
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	-	USD	Annual
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-7.00M	USD	Annual
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	-	USD	Annual
Net cash flow hedges	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$17.00M	USD	Annual
Net cash flow hedges	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$-26.00M	USD	Annual
Net cash flow hedges	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$5.00M	USD	Annual
Pension and other postretirement benefits	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax`	$-20.00M	USD	Annual
Pension and other postretirement benefits	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax`	$61.00M	USD	Annual
Pension and other postretirement benefits	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax`	$168.00M	USD	Annual
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-1.60B	USD	Annual
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$967.00M	USD	Annual
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-314.00M	USD	Annual
Comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$7.67B	USD	Annual
Comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$9.34B	USD	Annual
Comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$2.73B	USD	Annual
Comprehensive (income) loss attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$16.00M	USD	Annual
Comprehensive (income) loss attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$24.00M	USD	Annual
Comprehensive (income) loss attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-12.00M	USD	Annual
Comprehensive income attributable to CVS Health	`ComprehensiveIncomeNetOfTax`	$7.69B	USD	Annual
Comprehensive income attributable to CVS Health	`ComprehensiveIncomeNetOfTax`	$2.71B	USD	Annual
Comprehensive income attributable to CVS Health	`ComprehensiveIncomeNetOfTax`	$9.31B	USD	Annual

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.